BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25060152)

  • 21. Superantigen-induced proliferation of human CD4+CD25- T cells is followed by a switch to a functional regulatory phenotype.
    Taylor AL; Llewelyn MJ
    J Immunol; 2010 Dec; 185(11):6591-8. PubMed ID: 21048104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?
    Hmida NB; Ben Ahmed M; Moussa A; Rejeb MB; Said Y; Kourda N; Meresse B; Abdeladhim M; Louzir H; Cerf-Bensussan N
    Am J Gastroenterol; 2012 Apr; 107(4):604-11. PubMed ID: 22108452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4+CD25+Foxp3+IFN-γ+ human induced T regulatory cells are induced by interferon-γ and suppress alloresponses nonspecifically.
    Daniel V; Sadeghi M; Wang H; Opelz G
    Hum Immunol; 2011 Sep; 72(9):699-707. PubMed ID: 21664396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functionally distinct subsets of CD4⁺ regulatory T cells in patients with laryngeal squamous cell carcinoma are indicative of immune deregulation and disease progression.
    Sun W; Li WJ; Fu QL; Wu CY; Lin JZ; Zhu XL; Hou WJ; Wei Y; Wen YH; Wang YJ; Wen WP
    Oncol Rep; 2015 Jan; 33(1):354-62. PubMed ID: 25333227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
    Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment.
    Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
    Cancer Immunol Immunother; 2007 Sep; 56(9):1429-42. PubMed ID: 17265021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating naïve and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis.
    Miyoshi H; Uchida K; Taniguchi T; Yazumi S; Matsushita M; Takaoka M; Okazaki K
    Pancreas; 2008 Mar; 36(2):133-40. PubMed ID: 18376303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low circulating regulatory T-cell levels after acute rejection in liver transplantation.
    Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ
    Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis.
    Zen Y; Fujii T; Harada K; Kawano M; Yamada K; Takahira M; Nakanuma Y
    Hepatology; 2007 Jun; 45(6):1538-46. PubMed ID: 17518371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unique roles of Schistosoma japonicum protein Sj16 to induce IFN-γ and IL-10 producing CD4(+)CD25(+) regulatory T cells in vitro and in vivo.
    Sun XJ; Li R; Sun X; Zhou Y; Wang Y; Liu XJ; Lu Q; Zhou CL; Wu ZD
    Parasite Immunol; 2012; 34(8-9):430-9. PubMed ID: 22712636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients.
    Li L; Lao SH; Wu CY
    Tuberculosis (Edinb); 2007 Nov; 87(6):526-34. PubMed ID: 17851131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4+ CD25+ regulatory T cells in human pregnancy: development of a Treg-MLC-ELISPOT suppression assay and indications of paternal specific Tregs.
    Mjösberg J; Berg G; Ernerudh J; Ekerfelt C
    Immunology; 2007 Apr; 120(4):456-66. PubMed ID: 17229266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased proportion of CD4(+)CD25(+)Foxp3(+) regulatory T cells during early-stage sepsis in ICU patients.
    Leng FY; Liu JL; Liu ZJ; Yin JY; Qu HP
    J Microbiol Immunol Infect; 2013 Oct; 46(5):338-44. PubMed ID: 22921804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-10 and TGF-beta immunoregulatory cytokines rather than natural regulatory T cells are associated with the resolution phase of Vogt-Koyanagi-Harada (VKH) syndrome.
    Commodaro AG; Peron JP; Genre J; Arslanian C; Sanches L; Muccioli C; Rizzo LV; Belfort R
    Scand J Immunol; 2010 Jul; 72(1):31-7. PubMed ID: 20591073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis.
    Lewkowicz N; Lewkowicz P; Dzitko K; Kur B; Tarkowski M; Kurnatowska A; Tchórzewski H
    J Oral Pathol Med; 2008 Sep; 37(8):454-61. PubMed ID: 18318707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
    Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
    Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
    Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
    Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Porcine reproductive and respiratory syndrome virus induces CD4+CD8+CD25+Foxp3+ regulatory T cells (Tregs).
    Silva-Campa E; Mata-Haro V; Mateu E; Hernández J
    Virology; 2012 Aug; 430(1):73-80. PubMed ID: 22609353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.